Health provision integration platform Healthify has now raised $28m in equity and grants after a series B round involving BlueCross BlueShield Venture Partners.

Honeywell Ventures was among the investors in drug manufacturing informatics company Bigfinite’s latest round, with the proceeds slated to grow the market for its platform.

MIT-founded machine learning software development engine company Neural Magic picked up support from Comcast Ventures for its approach to executing ML models on commodity CPUs.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Lilly Asia Ventures returned for a $100m series C round, after the corporate venturing unit previously also backed a series B round of undisclosed size last year.

Co-founded by Innovative Targeting Solutions, A2 Biotherapeutics has emerged from stealth with $57m in series A financing to develop cell therapies for cancer.

Guangzhou Kingmed has led a $31m series C round for genome sequencing company Yikon Genomics, which was spun out of Harvard University five years ago.

Guangzhou Kingmed has led a $31m series C round for genome sequencing company Yikon Genomics, which was spun out of Harvard University five years ago.

Bayer has led a $25m series B round for Medopad, which allows patients to capture healthcare data through smartphones and watches.

UCSD-founded Shape Therapeutics has collected series A cash from NEA and CureDuchenne Ventures to progress its RNA gene editing technology.